Prohibits sale of cosmetic products and personal care products containing 1,4-dioxane.
Summary
Assembly Bill 1740 would prohibit the sale or offer for sale of cosmetic products and personal care products containing 1,4-dioxane, a hazardous chemical that can appear as a byproduct in the manufacture of certain ingredients used in cosmetics and cleansing products. The ban would take effect one year after enactment, while allowing only trace concentrations approved by the Commissioner of Environmental Protection. The bill defines the covered product categories broadly, but excludes prescription products.
The bill directs the Department of Environmental Protection to set allowable trace limits for 1,4-dioxane in these products, with a maximum of 10 parts per million for cosmetic products and a phased standard for personal care products that starts at no more than 2 parts per million and drops to 1 part per million after two years. The commissioner must also review the standards within three years to determine whether they should be lowered further to better protect human health and the environment. Manufacturers may seek a one-year waiver, and then one additional one-year waiver, if they can show they have taken steps to reduce 1,4-dioxane and still cannot comply.
Impact
If enacted, the bill would add a new environmental and consumer-product safety restriction to Title 13 of the Revised Statutes by barring the sale of certain cosmetics and personal care products containing 1,4-dioxane above permitted trace levels. It would give the Department of Environmental Protection regulatory authority to establish and later review concentration standards, and it would create a waiver process for manufacturers facing compliance difficulties. The measure would affect manufacturers, distributors, and retailers of cosmetics, shampoos, soaps, bath products, and similar personal care items sold in New Jersey.
Sentiment
The available context suggests a generally protective, public-health-oriented purpose, with the bill framed as a response to a hazardous substance and potential human carcinogen. The statement emphasizes reducing exposure and aligning New Jersey with a similar New York law, which indicates support for stronger product safety standards. No committee testimony, recorded votes, or opposition statements were provided, so there is no documented split in sentiment in the supplied materials.
Contention
The main policy tension in the bill is between consumer and environmental protection on one hand and manufacturing compliance burdens on the other. Supporters are likely to focus on reducing exposure to a potentially carcinogenic contaminant, while affected manufacturers and retailers may be concerned about the feasibility and cost of reformulating products, testing for trace contamination, and meeting phased-in limits. The waiver provisions appear designed to address those concerns by giving manufacturers limited additional time if they can show active efforts to reduce 1,4-dioxane and an inability to comply immediately.